Considering long-term outcome and tolerability in the treatment of bipolar disorder
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pshychiatric Mental Health
Link
http://link.springer.com/content/pdf/10.1007/BF02629432.pdf
Reference39 articles.
1. Lehmann HE, Hanrahan GL:Chlorpromazine: new inhibiting agent for psychomotor excitement and manic states.Arch Neurol Psychiatry 1954,71:227–237.
2. Post RM, Uhde TW, Ballenger JC, Squillace KM:Prophylactic efficacy of carbamazapine in manic-depressive illness.Am J Psychiatry 1983,140:1602–1604.
3. Yatham LN:Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.Bipolar Disord 2003,5(Suppl 2):7–19.
4. Wiesman M, Bland R, Canino G,et al.:Cross-national epidemiology of major depression and bipolar disorder.JAMA 1996,276:293–299.
5. Hirschfeld RMA, Calabrese JR, Weissman MM,et al.:Screening for bipolar disorder in the community.J Clin Psychiatry 2003,64:53–59.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3